Phase 2 NSCLC (Non-small Cell Lung Cancer) Clinical Trials
8 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–8 of 8 trials
Recruiting
Phase 2
Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital20 enrolled1 locationNCT07528274
Recruiting
Phase 1Phase 2
Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
NSCLC (Non-small Cell Lung Cancer)
Tang-Du Hospital20 enrolled1 locationNCT07354061
Recruiting
Phase 1Phase 2
Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas
LymphomaNSCLC (Non-small Cell Lung Cancer)Solid Advanced Tumor
OSE Immunotherapeutics41 enrolled11 locationsNCT05751798
Recruiting
Phase 2
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
MRDNSCLC (Non-small Cell Lung Cancer)II-IIIB Stages+1 more
Guangdong Association of Clinical Trials115 enrolled2 locationsNCT07120698
Recruiting
Phase 2
WAST Cell-Docetaxel Combination Therapy in PD-1 Inhibitor-Resistant Advanced NSCLC
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital31 enrolled1 locationNCT07330050
Recruiting
Phase 1Phase 2
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
Solid TumorNSCLC (Non-small Cell Lung Cancer)
Yuhan Corporation161 enrolled8 locationsNCT06616766
Recruiting
Phase 2
Cryoablation Combined With Tislelizumab and Chemotherapy as Neoadjuvant and Adjuvant Therapy in Resectable Stage II-IIIB NSCLC
NSCLC (Non-small Cell Lung Cancer)
Tianjin Medical University Cancer Institute and Hospital38 enrolled1 locationNCT06939127
Recruiting
Phase 2
Phase II Clinical Study of Befotertinib in EGFR Non-classical Mutant NSCLC
NSCLC (Non-small Cell Lung Cancer)
Second Affiliated Hospital, School of Medicine, Zhejiang University78 enrolled1 locationNCT06863506